$5.1 Billion Effort to Eradicate Polio Announced
THURSDAY, June 10, 2021 -- A $5.1 billion plan to eradicate polio worldwide by 2026 was announced this week by the Global Polio Eradication Initiative, a public-private partnership led by national governments and health groups.
For decades, the initiative has been trying to rid the world of polio by immunizing every child against the polio virus, but the COVID-19 pandemic interrupted that effort, leading to an increase in cases, The New York Times reported. There were 1,226 cases of polio worldwide in 2020, compared with 138 in 2018.
"Now is the time to double down and really make sure that we stop transmission and that we're able to deliver a polio-free world," said John Vertefeuille, chief of the polio eradication branch at the U.S. Centers for Disease Control and Prevention, one of the partners in the global initiative, The Times reported.
Progress is being made. Last August, African countries were declared free of wild poliovirus, which means that Afghanistan and Pakistan are the only two countries where polio remains endemic. Late last year, the World Health Organization gave emergency authorization to a new vaccine that could minimize polio outbreaks, The Times reported.
© 2021 HealthDay. All rights reserved.
Posted June 2021
Read this next
MONDAY, June 14, 2021 -- Individuals with inflammatory bowel disease (IBD) do not have an increased risk for adverse events (AEs) after the mRNA COVID-19 vaccination, according to...
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of June 7 to 11, 2021. This roundup...
FRIDAY, June 11, 2021 -- U.S. regulators have extended the expiration date on millions of Johnson & Johnson coronavirus vaccine doses by six weeks, the company announced...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.